We explored an innovative approach to treating blood clots using specially designed magnetic nanorobots that deliver nattokinase directly to targeted areas. These tiny robots are not only able to navigate through blood vessels but also use a combination of magnetic fields to break down clots effectively.
In a study involving thrombotic mice, these nattokinase-loaded nanorobots showed an impressive vasculature recanalization rate of 81%. This dual approach of mechanical damage and heat-triggered nattokinase release represents a significant advancement in noninvasive thrombolytic therapy.
Read More
We examined how a new treatment combining nattokinase with manganese oxide nanozymes might help with acute myocardial infarction, a serious heart condition often caused by blood clots.
Our study revealed that administering this innovative combination through injection significantly improved blood vessel function and decreased heart damage in mice.
The results suggest that these nattokinase-loaded nanozymes could offer a promising strategy to tackle heart attacks effectively, particularly through their antioxidant and thrombolytic properties.
Read More
Nattokinase milk shows cardiovascular promiseScreening of a Bacillus subtilis strain producing both nattokinase and milk-clotting enzyme and its application in fermented milk with thrombolytic activity.
High relevance for cardiovascular health
We explored the effectiveness of a specific strain of Bacillus subtilis in producing nattokinase to enhance fermented milk's health benefits. This probiotic contributed to significant thrombolytic activity, which helps prevent blood clots, a major factor in cardiovascular disease.
Our study demonstrated that fermented milk from B. subtilis could inhibit thrombosis in mice, indicating a promising way to integrate healthy options in our diets. Notably, sensory evaluations revealed that this functional fermented milk was well-accepted, similar to traditional options.
Overall, our findings highlight the potential of B. subtilis JNFE0126-fermented milk as a delicious, healthful alternative that may help reduce cardiovascular risks.
Read More
Nattokinase nanoparticles show promiseSynthesis of sustained release/controlled release nanoparticles carrying nattokinase and their application in thrombolysis.
High relevance for thrombolysis
We explored how nattokinase (NK), a strong clot-buster, can be delivered effectively using NK-conjugated magnetite nanoparticles (NK-MNPs). These nanoparticles were designed to release NK directly at the site of a thrombus and showed promising results in sustained release and thrombolytic potential.
After encapsulating NK, the nanoparticles demonstrated a successful release rate and maintained their efficacy even after storage. However, while the findings are encouraging, they suggest that NK-MNPs may not be a definitive solution but instead a promising avenue for further research into treating thrombus-related diseases.
Read More
We explored the potential of nattokinase, a promising thrombolytic agent, by creating stable nanocomposites using polylysine dendrimers. Through innovative methods, we ensured that nattokinase was effectively protected from environmental factors, enhancing its stability and activity.
When combined at a 1:30 molar ratio, these nanocomposites demonstrated a remarkable thrombolysis rate, effectively targeting blood clots while minimizing risk of complications. This research indicates that these nanostructures could pave the way for safer and more effective thrombolytic therapies.
Read More